Purchase Order 75N94020P00329

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $53,000 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide PacBio Sequel II sequencing services under a one-year agreement. The contract supports NICHD's research objectives by delivering next-generation DNA and RNA sequencing and analysis capabilities from January 2022 through January 2023. Pacific Biosciences will perform the sequencing services at its...

The National Institute of Child Health and Human Development (NICHD) awarded a $13,239.60 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Sequel II sequencing supplies under a total small business set-aside. The contract was awarded on July 24, 2025, with an ultimate completion date of July 23, 2026, and performance will take place in Menlo Park, California. This purchase order represents a consumables procurement supporting the NICHD's genomic research...

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $21,661 purchase order to Pacific Biosciences of California, Inc. for supplies and reagents to support the Sequel IIE sequencing platform. As a one-year firm fixed price contract set to run from July 2027 through July 2028, Pacific Biosciences will provide NICHD with the consumables needed for its genomic research and analysis efforts. No subcontractors or additional context was indicated....

<p>The National Institute of Child Health and Human Development awarded a purchase order to Pacific Biosciences of California, Inc. for $10,526.00 in reagent kits on February 28, 2018, with completion by January 31, 2019. Place of performance is Bethesda, Maryland. No set-aside was applied. The order carries firm fixed-price pricing.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Pacific Biosciences of California, Inc. for $10,208.00 on April 30, 2021, for SEQUEL II SEQUENCING KIT 2.0 BDLE (5-PK).</p> <p>Performance is located in North Bethesda, Maryland. The order carried a firm fixed price and was completed on April 30, 2021. No set-aside applied.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Illumina, Inc. for $102,585.72 on December 15, 2016, with a completion date of December 15, 2017. The order covers a comprehensive maintenance plan for HiSeq and MiSeq sequencers. Place of performance is Bethesda, Maryland. Pricing is firm fixed price.</p>

<p>The National Human Genome Research Institute awarded a $220,000 purchase order to Pacific Biosciences of California, Inc. on April 18, 2019 for a PacBio Sequel System 8M upgrade. Work is performed in Menlo Park, California, with an ultimate completion date of October 31, 2019. The order uses firm fixed-price pricing with no small business set-aside.</p>

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on October 8, 2020, with a ceiling value of $23,531.00 to perform high-throughput, large-scale DNA sequencing and sequence analysis. Work is performed in Menlo Park, California. The order carries firm fixed-price pricing and has an ultimate completion date of December 8, 2020.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Illumina, Inc. valued at $13,371.24 on January 26, 2017, for genetic sequencing and genomic analysis equipment or consumables, with performance completed by March 7, 2018. Place of performance is San Diego, California. The order carries no set-aside designation and is priced on a firm fixed-price basis.</p>

The National Institute of Child Health and Human Development (NICHD) awarded a one-year service agreement to Pacific Biosciences of California, Inc. valued at $57,320 for comprehensive maintenance and support of a Sequel II long-read sequencing instrument located in Bethesda, Maryland. The contract was awarded on January 26, 2026, following a sole-source Request for Quotation conducted under Simplified Acquisition Procedures, with the service period extending through January 25, 2027. The...